BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2924161)

  • 1. Diazepam binding inhibitor-like immunoreactivity(51-70): distribution in human brain, spinal cord and peripheral tissues.
    Ball JA; Ghatei MA; Sekiya K; Krausz T; Bloom SR
    Brain Res; 1989 Feb; 479(2):300-5. PubMed ID: 2924161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octadecaneuropeptide, benzodiazepine ligand, -like immunoreactivity in rat central nervous system, plasma and peripheral tissues.
    Ball JA; Burnet PW; Fountain BA; Ghatei MA; Bloom SR
    Neurosci Lett; 1986 Dec; 72(2):183-8. PubMed ID: 3808471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in diazepam binding inhibitor-like immunoreactivity (51-70) in Huntington's disease.
    Ball JA; Burnet PW; Bretherton-Watt D; Bloom SR
    J Neurol Sci; 1988 Dec; 88(1-3):177-84. PubMed ID: 2852215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and subcellular localization of an octadecaneuropeptide derived from diazepam binding inhibitor: immunohistochemical studies in the rat brain.
    Alho H; Bovolin P; Jenkins D; Guidotti A; Costa E
    J Chem Neuroanat; 1989; 2(6):301-18. PubMed ID: 2482048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A diazepam binding inhibitor (DBI)-like neuropeptide is detected in human brain.
    Ferrero P; Costa E; Conti-Tronconi B; Guidotti A
    Brain Res; 1986 Dec; 399(1):136-42. PubMed ID: 3801915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of a putative endogenous modulator of the GABAergic system in human brain.
    Ferrarese C; Appollonio I; Frigo M; Piolti R; Tamma F; Frattola L
    Neurology; 1989 Mar; 39(3):443-5. PubMed ID: 2927661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diazepam binding inhibitor processing in the rhesus monkey brain: an immunocytochemical study.
    Slobodyansky E; Kurriger G; Kultas-Ilinsky K
    J Chem Neuroanat; 1992; 5(2):169-80. PubMed ID: 1586472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution and characterization of diazepam binding inhibitor (DBI) in peripheral tissues of rat.
    Bovolin P; Schlichting J; Miyata M; Ferrarese C; Guidotti A; Alho H
    Regul Pept; 1990 Jul; 29(2-3):267-81. PubMed ID: 2171047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diazepam binding inhibitor (DBI) processing: immunohistochemical studies in the rat brain.
    Alho H; Bovolin P; Slobodyansky E
    Neurochem Res; 1990 Feb; 15(2):209-16. PubMed ID: 2159126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular location and neuronal release of diazepam binding inhibitor.
    Ferrarese C; Vaccarino F; Alho H; Mellstrom B; Costa E; Guidotti A
    J Neurochem; 1987 Apr; 48(4):1093-102. PubMed ID: 3819722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of diazepam binding inhibitor (DBI) processing products in human cerebrospinal fluid and in postmortem human brain.
    Guarneri P; Berkovich A; Guidotti A; Costa E
    Neuropharmacology; 1990 May; 29(5):419-28. PubMed ID: 2356001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rat brain regional distribution and spinal cord neuronal pathway of FLFQPQRF-NH2, a mammalian FMRF-NH2-like peptide.
    Majane EA; Panula P; Yang HY
    Brain Res; 1989 Aug; 494(1):1-12. PubMed ID: 2765908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ontogeny of diazepam-binding inhibitor-related peptides (endozepines) in the rat brain.
    Malagon M; Vaudry H; Van Strien F; Pelletier G; Gracia-Navarro F; Tonon MC
    Neuroscience; 1993 Dec; 57(3):777-86. PubMed ID: 8309536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute noise stress in rats increases the levels of diazepam binding inhibitor (DBI) in hippocampus and adrenal gland.
    Ferrarese C; Mennini T; Pecora N; Gobbi M; Appollonio I; Bernasconi P; Frigo M; Regondi C; Pierpaoli C; Frattola L
    Psychopharmacology (Berl); 1991; 103(3):339-42. PubMed ID: 2057538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diazepam binding inhibitor (DBI) increases after acute stress in rat.
    Ferrarese C; Mennini T; Pecora N; Pierpaoli C; Frigo M; Marzorati C; Gobbi M; Bizzi A; Codegoni A; Garattini S
    Neuropharmacology; 1991 Dec; 30(12B):1445-52. PubMed ID: 1664070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diazepam binding inhibitor peptide: cloning and gene expression.
    Mocchetti I; Santi MR
    Neuropharmacology; 1991 Dec; 30(12B):1365-71. PubMed ID: 1780035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protracted treatment with diazepam increases the turnover of putative endogenous ligands for the benzodiazepine/beta-carboline recognition site.
    Miyata M; Mocchetti I; Ferrarese C; Guidotti A; Costa E
    Proc Natl Acad Sci U S A; 1987 Mar; 84(5):1444-8. PubMed ID: 3029781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of diazepam binding inhibitor in human brain tumors.
    Alho H; Kolmer M; Harjuntausta T; Helén P
    Cell Growth Differ; 1995 Mar; 6(3):309-14. PubMed ID: 7794798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship of peptide fragments derived from DBI (diazepam binding inhibitor), a putative endogenous ligand of benzodiazepine recognition sites.
    Guidotti A; Santi MR; Berkovich A; Ferrarese C; Costa E
    Clin Neuropharmacol; 1986; 9 Suppl 4():217-9. PubMed ID: 3032426
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunohistochemistry of diazepam binding inhibitor (DBI) in the central nervous system and peripheral organs: its possible role as an endogenous regulator of different types of benzodiazepine receptors.
    Alho H; Harjuntausta T; Schultz R; Pelto-Huikko M; Bovolin P
    Neuropharmacology; 1991 Dec; 30(12B):1381-6. PubMed ID: 1664066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.